المستودع الأكاديمي جامعة المدينة

Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya

أعرض تسجيلة المادة بشكل مبسط

dc.contributor Médecins Sans Frontières, Nairobi, Kenya; National Tuberculosis Programme, Homa Bay, Kenya; Médecins Sans Frontières, Paris, France
dc.creator Huerga, H
dc.creator Spillane, H
dc.creator Guerrero, W
dc.creator Odongo, A
dc.creator Varaine, F
dc.date 2010-04-09
dc.date.accessioned 2017-01-31T07:21:50Z
dc.date.available 2017-01-31T07:21:50Z
dc.identifier Int J Tuberc Lung Dis 2010;14(5):611-5
dc.identifier 1815-7920
dc.identifier 20392355
dc.identifier http://hdl.handle.net/10144/114127
dc.identifier http://fieldresearch.msf.org/msf/handle/10144/114127
dc.identifier International Journal of Tuberculosis and Lung Disease
dc.identifier.uri http://dspace.mediu.edu.my:8181/xmlui/handle/10144/114127
dc.description SETTING: In July 2005, Médecins Sans Frontières and the Ministry of Health, Kenya, implemented an integrated tuberculosis-human immunodeficiency virus (TB-HIV) programme in western Kenya. OBJECTIVE: To evaluate the impact of an integrated TB-HIV programme on patient care and TB programme outcomes. DESIGN: Retrospective evaluation of three time periods: before (January-June 2005), shortly after (January-June 2006) and medium term after (January-December 2007) the implementation of the integrated programme. RESULTS: Respectively 79% and 91% of TB patients were HIV tested shortly and at medium term after service integration. The HIV-positive rate varied from 96% before the intervention to respectively 88% (305/347) and 74% (301/405) after. The estimated number of HIV-positive cases was respectively 303, 323 and 331 in the three periods. The proportion of patients receiving cotrimoxazole prophylaxis increased significantly from 47% (142/303) to 94% (303/323) and 86% (285/331, P < 0.05). Before the intervention, 87% (171/197) of the TB-HIV patients would have been missed when initiating antiretroviral treatment, compared to respectively 29% (60/210) and 36% (78/215) after the integration. The TB programme success rate increased from 56% (230/409) to 71% (319/447) in the third period (P < 0.05); however, there was no significant decrease in the default rate: 20% to 22% (P = 0.66) and 18% (P = 0.37). CONCLUSION: Integrated TB-HIV care has a very positive impact on the management of TB-HIV patients and on TB treatment outcomes.
dc.language en
dc.relation http://www.ncbi.nlm.nih.gov/pubmed/20392355
dc.rights Archived with thanks to The International Journal of Tuberculosis and Lung Disease : the official journal of the International Union against Tuberculosis and Lung Disease
dc.title Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya
dc.type Article


الملفات في هذه المادة

الملفات الحجم الصيغة عرض

لا توجد أي ملفات مرتبطة بهذه المادة.

هذه المادة تبدو في المجموعات التالية:

أعرض تسجيلة المادة بشكل مبسط